Keywords: sepracor, submits, nda, levalbuterol, submitted, new, drug

Sepracor Submits NDA For Levalbuterol

Article | 09 July 1997

Print This

Sepracor has submitted a New Drug Application to the US Food and DrugAdministration for approval to market levalbuterol HCl inhalation ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in